Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Operating Expenses (2016 - 2025)

Harte Hanks (HHS) has disclosed Operating Expenses for 16 consecutive years, with $6.6 million as the latest value for Q2 2025.

  • On a quarterly basis, Operating Expenses rose 12.83% to $6.6 million in Q2 2025 year-over-year; TTM through Sep 2025 was $55.3 million, a 15.11% increase, with the full-year FY2024 number at $183.1 million, up 128.25% from a year prior.
  • Operating Expenses was $6.6 million for Q2 2025 at Harte Hanks, down from $48.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $95.2 million in Q3 2024 to a low of -$53.1 million in Q4 2023.
  • A 5-year average of $38.4 million and a median of $45.7 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: skyrocketed 579.12% in 2021, then crashed 203.36% in 2023.
  • Harte Hanks' Operating Expenses stood at $49.1 million in 2021, then increased by 4.53% to $51.3 million in 2022, then plummeted by 203.36% to -$53.1 million in 2023, then skyrocketed by 191.73% to $48.7 million in 2024, then tumbled by 86.44% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Operating Expenses are $6.6 million (Q2 2025), $48.7 million (Q4 2024), and $95.2 million (Q3 2024).